Articles |
the Department of Pathology, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada.
The ability of the rabbit aorta intima-media (IM) layer to adsorb certain plasma proteins was measured for up to 20 months after a deendothelializing injury in vivo. Purified radioiodinated rabbit fibrinogen, antithrombin, or prothrombin was injected intravenously into either uninjured or sham-injured rabbits (controls) or rabbits at various times (5 minutes to 20 months) after a balloon-catheter injury to the aorta. After a 10-minute circulation time, a blood sample was taken, and the rabbit was exsanguinated rapidly (via a carotid cannula) and the aorta excised. Uptake of each radiolabeled protein was measured as bound radioactivity per square centimeter of platelet- or endothelium-free aorta IM and was compared with the radioactivity (ergo concentration) in blood at exsanguination. Fibrinogen adsorption by the IM was maximal at 5 minutes after injury (10.9±2.3 pmol/cm2 IM) and declined slowly to 4 to 6 pmol/cm2 at 12 months (controls: 0.8±0.1 pmol/cm2). Uptake of prothrombin (3.7±0.5 pmol/cm2 at 5 minutes) decreased to
2 pmol/cm2 at 12 months (controls: 0.3 pmol/cm2). Antithrombin adsorption by the IM (3.3±0.4 pmol/cm2 at 5 minutes) paralleled that of prothrombin over 12 months (controls: 0.3 to 0.4 pmol/cm2), the molar ratio ranging from 0.8 to 1.2. At 20 months, the ballooned aorta had a significantly thickened intima and was
90% reendothelialized. Injection of horseradish peroxidase (HRP) into rabbits at 1 or 12 months after balloon injury showed clearly that HRP activity was present throughout the entire depth of the deendothelialized, but not the reendothelialized, thickened intima. These results may indicate that an elevated turnover of hemostatic proteins continues within the deendothelialized intima after injury, conceivably until reendothelialization is complete.
Key Words: fibrinogen prothrombin antithrombin aortic intima balloon-catheter deendothelializing injury reendothelialization
This article has been cited by other articles:
![]() |
J. A. Samis, G. D. Ramsey, J. B. Walker, M. E. Nesheim, and A. R. Giles Proteolytic processing of human coagulation factor IX by plasmin Blood, February 1, 2000; 95(3): 943 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Becker, F. A. Spencer, Y. Li, S. P. Ball, Y. Ma, T. Hurley, and J. Hebert Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: Potential mechanisms for heightened prothrombotic potential J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1020 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Plescia, M. S. Conte, G. VanMeter, G. Ambrosini, and D. C. Altieri Molecular Identification of the Cross-reacting Epitope on alpha Mbeta 2 Integrin I Domain Recognized by Anti-alpha IIbbeta 3 Monoclonal Antibody 7E3 and Its Involvement in Leukocyte Adherence J. Biol. Chem., August 7, 1998; 273(32): 20372 - 20377. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. C. Hatton, B. Ross, S. M. R. Southward, M. DeReske, and M. Richardson Pretreatment of Rabbits With Either Hirudin, Ancrod, or Warfarin Significantly Reduces the Immediate Uptake of Fibrinogen and Platelets by the Deendothelialized Aorta Wall After Balloon-Catheter Injury In Vivo Arterioscler Thromb Vasc Biol, May 1, 1998; 18(5): 816 - 824. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |